GlassScriptPhysician profile
Vickie R Alexander
NPI 1295517407
$5,612.74
in general payments reported to CMS, 2019-2025
11 companies · $818 in 2025
The $818 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $122 · 2024: $4,673 · 2025: $818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,968 · Food and Beverage: $2,645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,967.58 |
| Food and Beverage | $2,645.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,421.38 | 2024-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Abbvie INC. | $769.51 | 2024-2025 | |
| Curonix LLC | $661.04 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $297.97 | 2024-2025 | Relistor |
| Regeneron Pharmaceuticals, INC. | $149.98 | 2025 | Dupixent |
| Idorsia Pharmaceuticals US INC | $121.81 | 2023 | Quviviq |
| Valinor Pharma, LLC | $65.85 | 2024-2025 | Movantik |
| Novo Nordisk INC | $39.26 | 2024 | |
| Collegium Pharmaceutical, INC. | $34.71 | 2024 | Belbuca |
| Pfizer INC. | $29.10 | 2024 | |
| Vertos Medical, INC. | $22.13 | 2024 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vickie Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.